$14.90
-0.1-0.67%
Last update: Aug 11, 1:19 PM
AgomAb Therapeutics NV
AGMBNASDAQ
Earnings: H1 2026 Earnings were released on Thu Aug 6th, after the market close
AgomAb Therapeutics Earnings & Forecasts
AgomAb Therapeutics (AGMB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AgomAb Therapeutics Guidance
Recent Earnings Results
| Metric | H1 '26 | FY '25 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | — | $-1.79 |
| Actual | $-0.93 | $-166.72 |
| Surprise | — | -9214.0% |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '26E | Q3 '26E | Q4 '26E | FY '26E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.39 | $-0.47 | $-0.52 | $-1.84 |
| Revenue | ||||
| Consensus | — | — | — | — |
